Ocular manifestations of systemic malignancies

Sharon D. Solomon, Jennifer Hasenyager Smith, Joan O'Brien

Research output: Contribution to journalArticle

Abstract

Ocular manifestations of systemic malignancy are important for both the ophthalmologist and the internist to recognize because they may precede the diagnosis of cancer. This review of the current literature discusses the clinical manifestations etiology, and potential therapeutic interventions for a group of visual paraneoplastic syndromes, including carcinoma-associated retinopathy and melanoma-associated retinopathy. These conditions are characterized by elevated serum levels of autoantibodies directed against tumor antigen that cross-react with retinal proteins, resulting in rod and cone dysfunction. The clinical presentation, site of origin, frequency, and intraocular distribution of tumors metastatic to the eye are also reviewed.

Original languageEnglish (US)
Pages (from-to)447-451
Number of pages5
JournalCurrent opinion in ophthalmology
Volume10
Issue number6
DOIs
StatePublished - Dec 15 1999
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Ocular manifestations of systemic malignancies'. Together they form a unique fingerprint.

Cite this